يعرض 241 - 260 نتائج من 8,165 نتيجة بحث عن '(( significant challenges decrease ) OR ( significantly ((we decrease) OR (linear decrease)) ))', وقت الاستعلام: 0.77s تنقيح النتائج
  1. 241
  2. 242
  3. 243
  4. 244
  5. 245

    Predicted behavioural expression of young (orange) and old (blue) individuals that do (treatment) or do not (control) receive an immune challenge. حسب Antoine Bour (20489426)

    منشور في 2024
    "…<p>(a) If an immune challenge causes sickness behaviour then we expect that young and old immune-challenged individuals will decrease their population-level average behavioural expression compared with controls with old individuals decreasing their behavioural expression more than young individuals. …"
  6. 246
  7. 247
  8. 248
  9. 249
  10. 250
  11. 251
  12. 252
  13. 253
  14. 254
  15. 255
  16. 256

    Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx حسب Guodong Huang (1595956)

    منشور في 2024
    "…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…"
  17. 257

    Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx حسب Guodong Huang (1595956)

    منشور في 2024
    "…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…"
  18. 258

    Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx حسب Guodong Huang (1595956)

    منشور في 2024
    "…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…"
  19. 259
  20. 260